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Ana Carolina de Carvalho1,3, Cristovam Scapulatempo-Neto2, Danielle Calheiros Campelo Maia1,
Adriane Feijó Evangelista3, Mariana Andozia Morini2, André Lopes Carvalho4,7* and André Luiz Vettore5,6,8*Author´s correction note
Upon reviewing our recently published research article
[1], we noticed that some of the data presented in the
manuscript and on the tables were incorrectly pre-
sented. These mistakes do not change the overall con-
clusions regarding the high accuracy of miR-203 and
miR-205 as diagnostic markers of neck metastases in
HNSCC.
Corrected text
1. (Page 8: End of “Validation and diagnostic accuracy of
miR-203 and miR-205 expression in FNA samples”)
Please replace
All in all, the sensitivity rate for both markers was
92.9 % (39/42, CI 95 %, 80.5–98.4), with a specificity
level of 100 % (71/71, CI 95 %, 94.9–100) (Table 2;
Figure 6B).
With the amended text
All in all, the sensitivity rate for both markers was 93.3 %
(42/45, CI 95 %, 81.7–98.6), with a specificity level of 100 %
(68/68, CI 95 %, 94.7–100) (Table 2; Figure 6B).
2. (Page 8: End of “Validation and diagnostic accuracy of
miR-203 and miR-205 expression in FNA samples”)
Please replace
Moreover, negative predictive values were of 95.9 %
(95 % CI, 88.6–99.1 %) and positive predictive values* Correspondence: alopescarvalho@gmail.com; andre.vettore@gmail.com
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creativecommons.org/publicdomain/zero/1.0/of 100 % (95 % CI, 90.9–100 %) for both microRNAs
(Table 3).With the amended text
Moreover, negative predictive values were of 95.9 %
(95 % CI, 88.6–99.1 %) and positive predictive values of
100% (95 % CI, 91.5–100 %) for both microRNAs
(Table 3).ess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
3. (Page 8: Table 2) - Please replace:
Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in
FFPE and FNA biopsies from lymph node samples
microRNA Sensitivity Specificity
Cutoffa Metastaticb Macrometastases Micrometastases Isolated tumor cells Non-metastatic
% (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n)
FFPE samples
miR-200a 5.96 76.0 (54.5-89.8) (19/25) 94.4 (70.6-99.7) (17/18) 40.0 (7.3-82.9) (2/5) 0 (0–80.2) (0/2) 100 (71.7-100) (13/13)
miR-200c 2.33 88.0 (67.7-96.8) (22/25) 100 (78.1-100) (17/18) 80.0 (29.9-98.9) (4/5) 0 (0–80.2) (0/2) 100 (71.7-100)) (13/13)
miR-203 1.96 100 (83.4-100) (25/25) 100 (78.1-100) (17/18) 100 (46.3-100) (5/5) 100 (19.8-100) (2/2) 100 (71.7-100) (13/13)
miR-205 1.54 100 (83.4-100) (25/25) 100 (78.1-100) (17/18) 100 (46.3-100) (5/5) 100 (19.8-100) (2/2) 100 (71.7-100) (13/13)
FNA samples classified by cytology
miR-203 10 100 (91.5-100) (42/42) 100 (91.5-100) (42/42) N/A N/A 100 (94.9-100) (71/71)
miR-205 10 100 (91.5-100) (42/42) 100 (91.5-100) (42/42) N/A N/A 100 (94.9-100) (71/71)
FNA samples classified by histology
miR-203 10 92.9 (80.5-98.4) (68/71) 100 (89.3-100) (68/68) 0 (0) (0/2) 0 (0) (0/1) 100 (94.9-100) (71/71)
miR-205 10 92.9 (80.5-98.4) (68/71) 100 (89.3-100) (68/68) 0 (0) (0/2) 0 (0) (0/1) 100 (94.9-100) (71/71)
FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the ROC curve;
CI, confidence interval; N/A, not applicable, FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative
predictive value; AUC, area under the ROC curve; CI, confidence interval
athe cutoff values for FFPE samples were determined according to the Youden index (value in which the difference between sensitivity and 1-specificity is
maximum) obtained from the ROC curves
bthe "metastatic" group comprises all cases with positive lymph nodes (macrometastases, micrometastases or isolated tumor cells)
With the amended table:
Table 2 Sensitivity and specificity values of microRNAs evaluated in discriminating metastatic and non-metastatic lymph nodes in
FFPE and FNA biopsies from lymph node samples
microRNA Sensitivity Specificity
Cutoffa Metastaticb Macrometastases Micrometastases Isolated tumor cells Non-metastatic
% (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n) % (95 % CI) (n)
FFPE samples
miR-200a 5.96 76.0 (54.5-89.8) (19/25) 94.4 (70.6-99.7) (17/18) 40.0 (7.3-82.9) (2/5) 0 (0–80.2) (0/2) 100 (71.7-100) (13/13)
miR-200c 2.33 88.0 (67.7-96.8) (22/25) 100 (78.1-100) (18/18) 80.0 (29.9-98.9) (4/5) 0 (0–80.2) (0/2) 100 (71.7-100)) (13/13)
miR-203 1.96 100 (83.4-100) (25/25) 100 (78.1-100) (18/18) 100 (46.3-100) (5/5) 100 (19.8-100) (2/2) 100 (71.7-100) (13/13)
miR-205 1.54 100 (83.4-100) (25/25) 100 (78.1-100) (18/18) 100 (46.3-100) (5/5) 100 (19.8-100) (2/2) 100 (71.7-100) (13/13)
FNA samples classified by cytology
miR-203 10 100 (91.5-100) (42/42) 100 (91.5-100) (42/42) N/A N/A 100 (94.9-100) (71/71)
miR-205 10 100 (91.5-100) (42/42) 100 (91.5-100) (42/42) N/A N/A 100 (94.9-100) (71/71)
FNA samples classified by histology
miR-203 10 93.3 (81.7-98.6) (42/45) 100 (91.5-100) (42/42) 0 (0) (0/2) 0 (0) (0/1) 100 (94.7-100) (68/68)
miR-205 10 93.3 (81.7-98.6) (42/45) 100 (91.5-100) (42/42) 0 (0) (0/2) 0 (0) (0/1) 100 (94.7-100) (68/68)
FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the ROC curve;
CI, confidence interval; N/A, not applicable, FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative
predictive value; AUC, area under the ROC curve; CI, confidence interval
athe cutoff values for FFPE samples were determined according to the Youden index (value in which the difference between sensitivity and 1-specificity is
maximum) obtained from the ROC curves
bthe "metastatic" group comprises all cases with positive lymph nodes (macrometastases, micrometastases or isolated tumor cells)
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4. (Page 10: Table 3) - Please replace:
Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA
biopsies from lymph node samples
microRNA PPV NPV Accuracy AUC (95 % CI)
% (95 % CI) % (95 % CI) % (95 % CI)
FFPE samples
miR-200a 100 (82.2-100.0) 68.4 (43.5-87.3) 84.2 (68.1-93.4) 0.92 (0.83-0.99)
miR-200c 100 (84.4-100.0) 81.2 (54.34-95.73) 92.1 (77.5-97.9) 0.94 (0.85-1.0)
miR-203 100 (86.2-100) 100 (75.1-100) 100 (88.6-100) 1.0 (0–1.0)
miR-205 100 (86.2-100) 100 (75.1-100) 100 (88.6-100) 1.0 (0–1.0)
FNA samples classified by cytology
miR-203 100 (91.5-100) 100 (94.9-100) 100 (96.05-100) 1.0 (0–1.0)
miR-205 100 (91.5-100) 100 (94.9-100) 100 (96.05-100) 1.0 (0–1.0)
FNA samples classified by histology
miR-203 100 (90.9-100) 95.9 (88.6-99.1) 97.3 (92.1-99.4) 0.963 (0.921-1.0)
miR-205 100 (93.2-100) 94.6 (85.1-98.8) 96.7 (93.1-100) 0.966 (0.921-1.0)
FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the ROC curve;
CI, confidence interval
With the amended table:
Table 3 Accuracy characteristics of microRNAs in discriminating metastatic and non-metastatic lymph nodes in FFPE and FNA
biopsies from lymph node samples
microRNA PPV NPV Accuracy AUC (95 % CI)
% (95 % CI) % (95 % CI) % (95 % CI)
FFPE samples
miR-200a 100 (82.2-100.0) 68.4 (43.5-87.3) 84.2 (68.1-93.4) 0.92 (0.83-0.99)
miR-200c 100 (84.4-100.0) 81.2 (54.34-95.73) 92.1 (77.5-97.9) 0.94 (0.85-1.0)
miR-203 100 (86.2-100) 100 (75.1-100) 100 (88.6-100) 1.0 (0–1.0)
miR-205 100 (86.2-100) 100 (75.1-100) 100 (88.6-100) 1.0 (0–1.0)
FNA samples classified by cytology
miR-203 100 (91.5-100) 100 (94.9-100) 100 (96.05-100) 1.0 (0–1.0)
miR-205 100 (91.5-100) 100 (94.9-100) 100 (96.05-100) 1.0 (0–1.0)
FNA samples classified by histology
miR-203 100 (91.5-100) 95.9 (88.6-99.1) 97.3 (92.1-99.4) 0.963 (0.921-1.0)
miR-205 100 (91.5-100) 95.9 (88.6-99.1) 97.3 (92.1-99.4) 0.966 (0.921-1.0)
FFPE, formalin-fixed paraffin embedded; FNA, fine-needle aspiration; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the ROC curve;
CI, confidence interval
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